310 related articles for article (PubMed ID: 29185275)
21. SOX14 hypermethylation as a tumour biomarker in cervical cancer.
Zhao J; Cao H; Zhang W; Fan Y; Shi S; Wang R
BMC Cancer; 2021 Jun; 21(1):675. PubMed ID: 34098886
[TBL] [Abstract][Full Text] [Related]
22. Lavage of the Uterine Cavity for Molecular Detection of Müllerian Duct Carcinomas: A Proof-of-Concept Study.
Maritschnegg E; Wang Y; Pecha N; Horvat R; Van Nieuwenhuysen E; Vergote I; Heitz F; Sehouli J; Kinde I; Diaz LA; Papadopoulos N; Kinzler KW; Vogelstein B; Speiser P; Zeillinger R
J Clin Oncol; 2015 Dec; 33(36):4293-300. PubMed ID: 26552420
[TBL] [Abstract][Full Text] [Related]
23. Triage of Atypical Glandular Cell by SOX1 and POU4F3 Methylation: A Taiwanese Gynecologic Oncology Group (TGOG) Study.
Chang CC; Ou YC; Wang KL; Chang TC; Cheng YM; Chen CH; Chu TY; Hsu ST; Liou WS; Chang YY; Wu HH; Chen TH; Lai HC
PLoS One; 2015; 10(6):e0128705. PubMed ID: 26057869
[TBL] [Abstract][Full Text] [Related]
24. Triage of high-risk human papillomavirus-positive women by methylated POU4F3.
Pun PB; Liao YP; Su PH; Wang HC; Chen YC; Hsu YW; Huang RL; Chang CC; Lai HC
Clin Epigenetics; 2015; 7(1):85. PubMed ID: 26300990
[TBL] [Abstract][Full Text] [Related]
25. DNA methylation testing for endometrial cancer detection in urine, cervicovaginal self-samples and cervical scrapes.
Wever BMM; van den Helder R; van Splunter AP; van Gent MDJM; Kasius JC; Trum JW; Verhoeve HR; van Baal WM; Hulbert A; Verhoef L; Heideman DAM; Lissenberg-Witte BI; van Trommel NE; Steenbergen RDM; Bleeker MCG
Int J Cancer; 2023 Jul; 153(2):341-351. PubMed ID: 36912267
[TBL] [Abstract][Full Text] [Related]
26. The impact of histological subtype in developing both ovarian and endometrial cancer: A longstanding nationwide incidence study.
van Niekerk CC; van Dijck JAAM; Verbeek ALM
Eur J Obstet Gynecol Reprod Biol; 2018 Feb; 221():17-22. PubMed ID: 29227847
[TBL] [Abstract][Full Text] [Related]
27. The WID-EC test for the detection and risk prediction of endometrial cancer.
Barrett JE; Jones A; Evans I; Herzog C; Reisel D; Olaitan A; Mould T; MacDonald N; Doufekas K; Newton C; Crosbie EJ; Bjørge L; Colombo N; Dostalek L; Costas L; Peremiquel-Trillas P; Ponce J; Matias-Guiu X; Zikan M; Cibula D; Wang J; Sundström K; Dillner J; Widschwendter M
Int J Cancer; 2023 May; 152(9):1977-1988. PubMed ID: 36533702
[TBL] [Abstract][Full Text] [Related]
28. Combining copy number, methylation markers, and mutations as a panel for endometrial cancer detection via intravaginal tampon collection.
Sangtani A; Wang C; Weaver A; Hoppman NL; Kerr SE; Abyzov A; Shridhar V; Staub J; Kocher JA; Voss JS; Podratz KC; Wentzensen N; Kisiel JB; Sherman ME; Bakkum-Gamez JN
Gynecol Oncol; 2020 Feb; 156(2):387-392. PubMed ID: 31787246
[TBL] [Abstract][Full Text] [Related]
29. Discovery of potential serum and urine-based microRNA as minimally-invasive biomarkers for breast and gynecological cancer.
Ritter A; Hirschfeld M; Berner K; Jaeger M; Grundner-Culemann F; Schlosser P; Asberger J; Weiss D; Noethling C; Mayer S; Erbes T
Cancer Biomark; 2020; 27(2):225-242. PubMed ID: 32083575
[TBL] [Abstract][Full Text] [Related]
30. Field methylation silencing of the protocadherin 10 gene in cervical carcinogenesis as a potential specific diagnostic test from cervical scrapings.
Wang KH; Liu HW; Lin SR; Ding DC; Chu TY
Cancer Sci; 2009 Nov; 100(11):2175-80. PubMed ID: 19709077
[TBL] [Abstract][Full Text] [Related]
31. Prediction of histologic type and lymph node metastasis for advanced ovarian cancer on uterine cervical and endometrial cytology.
Suzuki M; Suzuki T; Matsuura M; Iwasaki M; Tanaka R; Ito E; Fujii M; Saito T
Acta Cytol; 2010; 54(4):575-81. PubMed ID: 20715659
[TBL] [Abstract][Full Text] [Related]
32. Diagnosing endometrial carcinoma with cervical involvement by cervical cytology.
Morimura Y; Nishiyama H; Hashimoto T; Takano Y; Yamada H; Yanagida K; Sato A
Acta Cytol; 2002; 46(2):284-90. PubMed ID: 11917574
[TBL] [Abstract][Full Text] [Related]
33. Methylation status and expression of human telomerase reverse transcriptase in ovarian and cervical cancer.
Widschwendter A; Müller HM; Hubalek MM; Wiedemair A; Fiegl H; Goebel G; Mueller-Holzner E; Marth C; Widschwendter M
Gynecol Oncol; 2004 May; 93(2):407-16. PubMed ID: 15099954
[TBL] [Abstract][Full Text] [Related]
34. An investigation of relationships between hypoxia-inducible factor-1 alpha gene polymorphisms and ovarian, cervical and endometrial cancers.
Konac E; Onen HI; Metindir J; Alp E; Biri AA; Ekmekci A
Cancer Detect Prev; 2007; 31(2):102-9. PubMed ID: 17418979
[TBL] [Abstract][Full Text] [Related]
35. Methylated DNA markers for plasma detection of ovarian cancer: Discovery, validation, and clinical feasibility.
Marinelli LM; Kisiel JB; Slettedahl SW; Mahoney DW; Lemens MA; Shridhar V; Taylor WR; Staub JK; Cao X; Foote PH; Burger KN; Berger CK; O'Connell MC; Doering KA; Giakoumopoulos M; Berg H; Volkmann C; Solsrud A; Allawi HT; Kaiser M; Vaccaro AM; Albright Crawford C; Moehlenkamp C; Shea G; Deist MS; Schoolmeester JK; Kerr SE; Sherman ME; Bakkum-Gamez JN
Gynecol Oncol; 2022 Jun; 165(3):568-576. PubMed ID: 35370009
[TBL] [Abstract][Full Text] [Related]
36. Circular RNAs: Novel biomarkers for cervical, ovarian and endometrial cancer (Review).
Shi Y; He R; Yang Y; He Y; Shao K; Zhan L; Wei B
Oncol Rep; 2020 Nov; 44(5):1787-1798. PubMed ID: 33000238
[TBL] [Abstract][Full Text] [Related]
37. Combined clinical and genetic testing algorithm for cervical cancer diagnosis.
Liou YL; Zhang TL; Yan T; Yeh CT; Kang YN; Cao L; Wu N; Chang CF; Wang HJ; Yen C; Chu TY; Zhang Y; Zhang Y; Zhou H
Clin Epigenetics; 2016; 8():66. PubMed ID: 27293491
[TBL] [Abstract][Full Text] [Related]
38. Mutational analysis of cervical cytology improves diagnosis of endometrial cancer: A prospective multicentre cohort study.
Reijnen C; van der Putten LJM; Bulten J; Snijders MPLM; Küsters-Vandevelde HVN; Sweegers S; Vos MC; van der Wurff AAM; Ligtenberg MJL; Massuger LFAG; Eijkelenboom A; Pijnenborg JMA
Int J Cancer; 2020 May; 146(9):2628-2635. PubMed ID: 31523803
[TBL] [Abstract][Full Text] [Related]
39. Mutually distinguishing microRNA signatures of breast, ovarian and endometrial cancers in vitro.
Hirschfeld M; Ge I; Rücker G; Waldschmidt J; Mayer S; Jäger M; Voigt M; Kammerer B; Nöthling C; Berner K; Weiss D; Asberger J; Erbes T
Mol Med Rep; 2020 Nov; 22(5):4048-4060. PubMed ID: 33000259
[TBL] [Abstract][Full Text] [Related]
40. Discovery and validation of methylation markers for endometrial cancer.
Wentzensen N; Bakkum-Gamez JN; Killian JK; Sampson J; Guido R; Glass A; Adams L; Luhn P; Brinton LA; Rush B; d'Ambrosio L; Gunja M; Yang HP; Garcia-Closas M; Lacey JV; Lissowska J; Podratz K; Meltzer P; Shridhar V; Sherman ME
Int J Cancer; 2014 Oct; 135(8):1860-8. PubMed ID: 24623538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
